Biomea Fusion, Inc.
BMEANASDAQHealthcare● Active
$1.15
$-0.12(-9.45%)
Market Cap$68420740
P/E Ratio—
52W High$3.08
52W Low$0.872
Biomea Fusion, Inc. (BMEA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BMEA · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
-$0.17
Est. -$0.24 · +29.2%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
BMEA reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | -$0.21 | — | — | — | — | — |
| ▲ Q2 FY2026 | May 11, 2026 | -$0.24 | -$0.17 | +29.2% | — | — | — |
| ▼ Q1 FY2026 | Mar 24, 2026 | -$0.25 | -$0.64 | -156.0% | — | — | — |
| ▼ Q4 FY2025 | Nov 4, 2025 | -$0.26 | -$0.27 | -3.9% | — | — | — |
| ▲ Q3 FY2025 | Aug 5, 2025 | -$0.59 | -$0.51 | +13.6% | — | — | — |
| ▲ Q2 FY2025 | May 5, 2025 | -$0.84 | -$0.80 | +4.8% | — | — | — |
| ▲ Q1 FY2025 | Mar 31, 2025 | -$1.00 | -$0.81 | +19.0% | $0.00B | — | — |
| ▲ Q4 FY2024 | Oct 29, 2024 | -$1.05 | -$0.91 | +13.3% | — | — | — |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
-$0.21
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Beat
EPS Actual
-$0.17
EPS Est.
-$0.24
EPS Surpr.
+29.2%
Revenue
—
Q1 FY2026
Mar 24, 2026Miss
EPS Actual
-$0.64
EPS Est.
-$0.25
EPS Surpr.
-156.0%
Revenue
—
Q4 FY2025
Nov 4, 2025Miss
EPS Actual
-$0.27
EPS Est.
-$0.26
EPS Surpr.
-3.9%
Revenue
—
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
-$0.51
EPS Est.
-$0.59
EPS Surpr.
+13.6%
Revenue
—
Q2 FY2025
May 5, 2025Beat
EPS Actual
-$0.80
EPS Est.
-$0.84
EPS Surpr.
+4.8%
Revenue
—
Q1 FY2025
Mar 31, 2025Beat
EPS Actual
-$0.81
EPS Est.
-$1.00
EPS Surpr.
+19.0%
Revenue
$0.00B
Q4 FY2024
Oct 29, 2024Beat
EPS Actual
-$0.91
EPS Est.
-$1.05
EPS Surpr.
+13.3%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.24 | $-0.24 | $-0.24 | 3 |
| Q3 FY2028 | $-0.22 | $-0.22 | $-0.22 | 2 |
| Q2 FY2028 | $-0.20 | $-0.20 | $-0.20 | 2 |
| Q1 FY2028 | $-0.21 | $-0.21 | $-0.21 | 3 |
| Q4 FY2027 | $-0.47 | $-0.47 | $-0.47 | 2 |
| Q3 FY2027 | $-0.22 | $-0.22 | $-0.22 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 11, 2026 | +29.2% | $1.54 | $1.57 | +1.95% |
| ▼ Q1 FY2026 | Mar 24, 2026 | -156.0% | $1.12 | $1.13 | +0.89% |
| ▼ Q4 FY2025 | Nov 4, 2025 | -3.9% | $1.32 | $1.26 | -4.55% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +13.6% | $1.61 | $1.58 | -1.86% |
| ▲ Q2 FY2025 | May 5, 2025 | +4.8% | $2.18 | $2.00 | -8.26% |
| ▲ Q1 FY2025 | Mar 31, 2025 | +19.0% | $2.30 | $2.13 | -7.39% |
| ▲ Q4 FY2024 | Oct 29, 2024 | +13.3% | $12.41 | $12.06 | -2.82% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +0.0% | $5.32 | $5.57 | +4.70% |
Q2 FY2026+1.95%
Report Date
May 11, 2026
EPS Beat/Miss
+29.2%
Price Before
$1.54
Price After
$1.57
Q1 FY2026+0.89%
Report Date
Mar 24, 2026
EPS Beat/Miss
-156.0%
Price Before
$1.12
Price After
$1.13
Q4 FY2025-4.55%
Report Date
Nov 4, 2025
EPS Beat/Miss
-3.9%
Price Before
$1.32
Price After
$1.26
Q3 FY2025-1.86%
Report Date
Aug 5, 2025
EPS Beat/Miss
+13.6%
Price Before
$1.61
Price After
$1.58
Q2 FY2025-8.26%
Report Date
May 5, 2025
EPS Beat/Miss
+4.8%
Price Before
$2.18
Price After
$2.00
Q1 FY2025-7.39%
Report Date
Mar 31, 2025
EPS Beat/Miss
+19.0%
Price Before
$2.30
Price After
$2.13
Q4 FY2024-2.82%
Report Date
Oct 29, 2024
EPS Beat/Miss
+13.3%
Price Before
$12.41
Price After
$12.06
Q3 FY2024+4.70%
Report Date
Jul 31, 2024
EPS Beat/Miss
+0.0%
Price Before
$5.32
Price After
$5.57
Avg Beat Reaction-2.28%
Avg Miss Reaction-1.83%
Beat Rate6 / 8 quarters
Largest Move-8.26% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BMEA ends December
Biomea Fusion, Inc. (BMEA) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $-0.17 — beating the analyst consensus of $-0.24 by +29.2%. The next BMEA earnings date is expected around September 1, 2026.
Each quarter, investors track BMEA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BMEA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BMEA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BMEA earnings · 5 questionsBiomea Fusion, Inc.'s next earnings report is expected around September 1, 2026. BMEA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BMEA historically reports after market close (AMC).
BMEA earnings datewhen is BMEA earningsBMEA next earnings datewhen does BMEA report earningsBMEA earnings calendar
▸ Source: FMP · Biomea Fusion, Inc. SEC filings · US GAAP · Biomea Fusion, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026